Activatable Antimicrobial Peptides and Uses Thereof

Disclosed herein are fusion protein, comprising (a) at least one X1 domain comprising a half-life extension compound, including but not limited to a half-life extension polypeptide; (b) at least one X2 domain comprising an anionic block; (c) at least one X3 domain comprising a linker susceptible to cleavage at a site of disease, including but not limited to a microbial infection site or tumor site; and (d) at least one X4 domain comprising a therapeutic peptide; wherein the at least one X1, X2, X3, and X4 domains are covalently linked, and each X4 domain is linked to an X3 domain without an intervening X1 or X2 domain; compositions containing such fusion proteins, and methods for their use.

Researchers

Sangeeta Bhatia / Chayanon Ngambenjawong

Departments: Health Sciences and Technology Program
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living

  • activatable therapeutic peptides and uses thereof
    Patent Cooperation Treaty | Published application
  • activatable therapeutic peptides and uses thereof
    United States of America | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.